NovoCure (NVCR) Q3 2024 Earnings

25JulConfirmed
Q3 2023
Q4 2023
Q1 2024
Q3 2024
-0.52
-0.45
-0.38
-0.31

Details

Expected EPS
-0.402857
Actual EPS
-0.31
Surprise EPS
0.09
Surprise Percent
+23.05%

Description

NovoCure (NVCR) has reported earnings of -0.31 per share for Q3 2024.

0 Comments

Share your thoughts